GlaxoSmithKline's Tanzeum gets FDA approval for type 2 diabetes treatment - 1 views
-
Alex Parker on 16 Apr 14GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.